These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 150239)

  • 1. Normal and 6-aminonicotinamide impaired development of capillarization in occipital cortex of rat.
    Rauchfuss A
    Anat Embryol (Berl); 1978 Jul; 154(1):27-37. PubMed ID: 150239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlated changes in neuronal cerebral rat brain RNA synthesis and hypo- and hypermotoric disorders induced by 6-aminonicotinamide (6-AN).
    Knoll-Köhler E; Wojnorowicz F; Sarkander HJ
    Exp Brain Res; 1980 Jan; 38(2):173-9. PubMed ID: 6444587
    [No Abstract]   [Full Text] [Related]  

  • 3. Actions of 6-aminonicotinamide on benzodiazepine receptors in rat CNS.
    Morgan PF; Stone TW
    Neurosci Lett; 1983 Sep; 40(1):51-4. PubMed ID: 6314203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ultrastructural reaction of the multipotential glia in the cerebellum of the rat after treatment with 6-aminonicotinamide].
    Schaarschmidt W; Lierse W
    Acta Anat (Basel); 1975; 93(2):184-93. PubMed ID: 128982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebellar malformation obtained in rats by early postnatal treatment with 6-aminonicotinamide. Role of neuron-glia interactions in cerebellar development.
    Sotelo C; Rio JP
    Neuroscience; 1980; 5(10):1737-59. PubMed ID: 6448965
    [No Abstract]   [Full Text] [Related]  

  • 6. Ultrastructure of 6-aminonicotinamide (6-an)--induced lesions in the central nervous system of rats.
    Horita N; Oyanagi S; Ishii T; Izumiyama Y
    Acta Neuropathol; 1978 Nov; 44(2):111-9. PubMed ID: 152558
    [No Abstract]   [Full Text] [Related]  

  • 7. [Embryonic development of hypophysis, adrenal glands and gonads in rat embryos after 6-aminonicotinamide administration].
    Seinsch W
    Verh Anat Ges; 1976; (70 Pt 1):139-45. PubMed ID: 139782
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of gamma-aminobutyric acid transaminase with 6-aminonicotinamide in regions of the rat brain.
    Prakash MR; Baouer NZ
    Biochem Pharmacol; 1981 Mar; 30(6):663-4. PubMed ID: 6456007
    [No Abstract]   [Full Text] [Related]  

  • 9. Ultrastructure of 6-aminonicotinamide (6-AN)-induced lesions in the central nervous system of rats. III. Alterations of the spinal gray matter lesion with aging.
    Horita N; Ishii T; Izumiyama Y
    Acta Neuropathol; 1981; 53(3):227-35. PubMed ID: 6452785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycolysis and glycogen metabolism after inhibition of hexose monophosphate pathway in C6-GLIAL cells.
    Keller K; Kolbe H; Herken H; Lange K
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Aug; 294(2):213-5. PubMed ID: 138094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electronmicroscopic study of the effect of 6-an on the sciatic nerve in newborn rats.
    Brzoska HR; Adhami H
    Acta Neuropathol; 1975 Oct; 33(1):59-66. PubMed ID: 126631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal gluconate excretion after 6-aminonicotinamide.
    Herken H; Keller K; Kolbe H; Lange K
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 291(2):213-6. PubMed ID: 127949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A scanning and transmission electron microscopic study of amoeboid microglial cells in the prenatal rat brain following a maternal injection of 6-aminonicotinamide.
    Tseng CY; Ling EA; Wong WC
    J Anat; 1984 Jun; 138 ( Pt 4)(Pt 4):733-43. PubMed ID: 6235203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The formation of capillary basement membranes during internal vascularization of the rat's cerebral cortex.
    Bär T; Wolff JR
    Z Zellforsch Mikrosk Anat; 1972; 133(2):231-48. PubMed ID: 5082884
    [No Abstract]   [Full Text] [Related]  

  • 15. Impaired dopamine function and muscular rigidity induced by 6-aminonicotinamide in rats.
    Kehr W; Halbhübner K; Loos D; Herken H
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Oct; 304(3):317-9. PubMed ID: 152412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of neonatal treatment with 6-aminonicotinamide on basal and isoproterenol-stimulated ornithine decarboxylase activity in cerebellum of the development rat.
    Morris G; Nadler JV; Nemeroff CB; Slotkin TA
    Biochem Pharmacol; 1985 Sep; 34(18):3281-4. PubMed ID: 2931085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased glycolytic flux rate in the isolated perfused rat brain after pretreatment with 6-aminonicotinamide.
    Krieglstein J; Stock R
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 290(2-3):323-7. PubMed ID: 127127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal cord acetylcholine content: the consequence of transection or treatment with the neurotoxin 6-aminonicotinamide.
    Potter PE; Neff NH
    Brain Res; 1984 Jun; 303(1):87-90. PubMed ID: 6234052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative studies in the cerebral cortex of aging humans.
    Hunziker O; Abdel'Al S; Frey H; Veteau MJ; Meier-Ruge W
    Gerontology; 1978; 24(1):27-31. PubMed ID: 618764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic modulation of acute uveitis with aminonicotinamide.
    Marak GE; Sery TW; Gregerson D; Donoso LA; Rao NA
    Ophthalmic Res; 1990; 22(2):111-6. PubMed ID: 2140443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.